In particular, treatment with wogonoside, a glucuronide metabolite of the bioactive flavonoid wogonin, reduced significantly colonic NF-κB and NLRP3 expression, as well as caspase-1 expression and activity in mice with colitis, exerting beneficial effects on colonic inflammation (69). This evidence concerns the gene NLRP3 and colitis.